on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a disclosure under Rule 8.3 of the Irish Takeover Panel Act, tracking its interest in Mural Oncology plc. The firm holds 772,561 ordinary shares at a nominal value of $0.01 each, representing a 4.47% stake in the company. This disclosure was made regarding positions held as of April 16, 2025.
No additional dealings or derivative positions were disclosed, and there are no indemnity or option arrangements in place with Mural Oncology or any concert party. Furthermore, there are no agreements pertaining to voting rights or future transactions involving the relevant securities. Vanguard affirms no supplemental Form 8 is required, indicating a straightforward position without additional complexities or derivative transactions.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news